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Abstract
Purpose—To evaluate the impact of dry eye syndrome (DES) on vision-associated quality of life.
Design—Cross-sectional study.
Methods—We identified 450 participants in the Women’s Health Study (WHS) and 240
participants in the Physicians’ Health Study (PHS) and sent a supplementary questionnaire asking
how much their everyday activities were limited by symptoms of dry eye and to what degree problems
with their eyes limited them in reading, driving, working at the computer, their professional activity,
and watching TV. By design, one-third of study subjects had clinically diagnosed DES or severe
symptoms and two-thirds did not. We used logistic regression to examine relationships of DES with
reported problems with everyday activities in each cohort and pooled estimates using meta-analysis
methods.
Results—Of the participants invited, 85% completed the supplementary questionnaire, including
135 WHS and 55 PHS participants with DES, and 250 WHS and 149 PHS participants without DES.
Controlling for age, diabetes, hypertension and other factors, those with DES were more likely to
report problems with reading (OR=3.64, 95% CI 2.45–5.40, P< 0.0001); carrying out professional
work (OR=3.49, 95% CI 1.72–7.09, P= 0.001); using a computer (OR=3.37, 95% CI 2.11–5.38, P<
0.0001); TV watching (OR=2.84, 95% CI 1.05–7.74, P=0.04); driving during the day (OR=2.80,
95% CI 1.58–4.96, P< 0.0001); and driving at night (OR=2.20, 95% CI 1.48–3.28, P<0.0001).
Conclusions—DES is associated with a measurable adverse impact on several common and
important tasks of daily living, further implicating this condition as an important public health
problem deserving increased attention and resources.
Introduction
Dry eye syndrome (DES) is recognized as a growing public health problem and one of the most
frequent reasons for seeking eye care.1–5 The estimated prevalence of DES for people ≥50
years in the US is 7.8% or 3.2 million among women and 4.7% or 1.6 million among men.3
Inclusion of less severe DES cases would add substantially to these overall numbers.4, 6 DES
is characterized by a deficiency in the quantity and/or quality of tears, an unstable tear film,
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ocular surface damage, and bothersome symptoms such as ocular irritation, dryness, fatigue,
and fluctuating visual disturbances.
Although some risk factors have been identified, the etiology of DES is still largely unknown.
2, 7–9 It is likely that the ever increasing demands of modern living that require prolonged
visual tasking may play a role in its development,10, 11 as well as in its consequences for
vision and vision-related quality of life.12 As this condition is more frequent in older age3,
13, 14 projections of greater life expectancy in developed countries will predictably result in
an even larger burden of DES on society through direct costs for care and treatment and indirect
costs associated with decreased visual function15 and quality of life.16
The importance of DES is usually clear to an individual patient and to his/her eye doctor, but
there are few published data to describe the impact of DES on quality of life.17, 18 We therefore
measured the impact of DES on visual function/quality of life by assessing its effect on several
common activities of daily living such as reading, driving, computer work, performing
professional work and watching television
Methods
Study population
The Women’s Health Study (WHS) was a randomized, double-masked, placebo-controlled
trial among 39,876 US female health professionals (actively working or retired) aged between
39 and 90 years at baseline to assess the benefits and risks of low-dose aspirin and vitamin E
in the primary prevention of cardiovascular disease and cancer among healthy women.19, 20
Information on general characteristics of the study population was ascertained on annual
questionnaires as has been previously reported.21 The Physicians’ Health Study (PHS) was a
randomized, double-masked, placebo-controlled trial to test the effect of low-dose aspirin and
beta-carotene in the primary prevention of cardiovascular disease and cancer among 22,071
healthy US male physicians, aged between 40 to 84 at baseline, in 1982. Annual questionnaires
were administered during the active treatment phase of the trial,22, 23 as well as during
continued observational follow-up of the PHS cohort. Informed Consent was obtained from
all study subjects, the study and data accumulation were carried out with approval from the
Institutional Review Board of Brigham and Women's Hospital, and the study is in accord with
HIPAA regulations.
Assessment of DES
We assessed participants’ history of DES beginning in 1997 using three questions: 1) “How
often are your eyes dry (not wet enough)?” and 2) “How often are your eyes irritated?” with
possible answers of constantly, often, sometimes, or never; and 3) “Have you ever been
diagnosed, by a clinician, as having dry eye syndrome?” and if so requesting the date of this
diagnosis. For the present study, we considered participants to have DES if they reported a
clinical diagnosis of DES and/or severe symptoms, defined as a response of constantly or often
to both the dryness and irritation questions.2, 3 At the time of assessment of DES, WHS
participants were aged 49 and older, while PHS participants were 55 years or older.
Selection of subgroup for the present study
For these analyses we selected subgroups of 450 WHS and 240 PHS participants based on their
answers to the three DES-related questions such that one-third of them satisfied our definition
of DES having reported clinically diagnosed DES and/or both dryness and irritation either
constantly or often. The other two-thirds of selected participants who did not meet those criteria
were frequency matched on age to the DES cases.
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Assessment of vision-related quality of life
We mailed a supplementary DES questionnaire, consisting of eleven questions, to the selected
subgroups of WHS and PHS participants. We asked several questions regarding the impact of
DES on vision-related quality of life. We included a global question: “How much do dry eye
symptoms limit your everyday activities?” and asked participants to grade the impact on a scale
of 0 to 10. We also asked the question: “Have problems with your eyes limited you in
performing any of the following activities during the last week?” and listed activities including
reading, driving during the day, driving at night, computer use, watching TV, and performing
professional work.” Possible answers ranged from all of the time, most of the time, half of the
time, some of the time, none of the time, or not applicable.
Statistical analysis
We initially examined the frequency distribution of participants’ answers to the questions
related to vision-related quality of life, and used the Wilcoxon Rank Sum test to check for an
association of each activity score with DES. Individuals who chose a response of not applicable
were excluded from analysis of that particular activity. In further analyses, we dichotomized
responses to the presence versus absence of any degree of problems with each activity, and
used logistic regression models to estimate the odds ratios (OR) and 95% confidence intervals
(CI) for the relationship of each activity of daily living with DES while controlling for potential
confounding variables. Because the two cohorts are independent, and available data differs in
the two cohorts, we fit separate models for women and men. Among women, we controlled
for age, educational level, household income, use of hormone replacement therapy, a history
of hypertension, diabetes, and connective tissue disease, and for whether or not the participant
had an eye exam in previous two years. Among men, we controlled for age, a history of
hypertension, diabetes, and benign prostate hypertrophy. Information on history of eye
examinations, income levels, and connective tissue diseases were not available in men, who
were all physicians and therefore of comparable educational level. We also investigated
whether the impact of dry eye on vision-related quality of life was modified by the use of
artificial tears by including an interaction term in the models. Finally, we tested for
heterogeneity across cohorts and used a random effects method weighted by the sample size
for each cohort to obtain pooled OR and 95% CI for the association of DES with each activity,
and overall.24
Results
Study Subjects Characteristics
Of the 450 WHS and 240 PHS participants selected, 85% (385 from WHS and 204 from PHS)
completed the supplementary DES questionnaire and were included in this analysis. Dry eye
was present in 135 women (41 who reported severe symptoms, 62 who had been diagnosed
with dry eye, and 31 who had both severe symptoms and a prior diagnosis of dry eye) and 55
men (17 who reported severe symptoms, 25 with diagnosed dry eye, and 13 with both severe
symptoms and a prior diagnosis of dry eye). Baseline characteristics of study participants are
presented in Table 1. The mean age for both the DES and the control groups was 57 years
among women, and 71 years among men. There was no statistically significant difference
between participants with DES and controls in regard to the presence of comorbid states such
as hypertension, diabetes and, among men, benign prostatic hypertrophy. However, as would
be expected, the presence of Sjogren’s syndrome among female participants with DES was
significantly greater than that among female controls (p=0.04), but there was not a significant
difference between female cases and controls in regard to the presence of any connective tissue
disease (p= 0.17).
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In our initial unadjusted analyses, we observed significant differences between participants
with DES and controls in both cohorts in regard to problems with reading, professional work,
and computer use (each p<0.001 for both women and men). However, for the activity of driving,
differences between subjects with and without DES were significantly different only among
women (daytime driving; p<0.001 for women and p=0.07 for men) (driving at night; p<0.001
for women and p=0.06 for men).
Using logistic regression models to control for potential confounding factors, we estimated the
impact of DES on the risk of having problems with each activity (Figure 1). The test for
heterogeneity across cohorts was not significant for most of the activities (reading, p=0.93;
professional work, p=0.21; computer use, p=0.56; driving during the day, p=0.39; driving at
night, p=0.70), with the exception of TV watching for which it was of borderline significance
(p=0.04). Pooled multivariate logistic regression estimates demonstrated significant
associations between the presence of DES and having problems with reading (OR=3.64, 95%
CI 2.45–5.40, p< 0.001); carrying out professional work (OR=3.49, 95% CI 1.72–7.09, p=
0.001); using computer (OR=3.37, 95% CI 2.11–5.38, p< 0.001); TV watching (OR=2.84, 95%
CI 1.05–7.74, p=0.04); driving during the day (OR=2.80, 95% CI 1.58–4.96, p< 0.001); and
driving at night (OR=2.20, 95% CI 1.48–3.28, p<0.001).
In addition, in both cohorts, participants with DES reported a significantly greater overall
impact of dry eye on problems with everyday activities (pooled OR=3.16, 95% CI 2.14–4.68,
p<0.001). Further analyses suggested that the impact of dry eye on everyday activities differed
depending on use of artificial tears (P for interaction<0.001). Whereas there was a 2.64-fold
increase in problems with everyday activities among those with dry eye who used artificial
tears, the increase was 4.80-fold among dry eye subjects who did not use artificial tears, as
presented in Figure 2.
Discussion
DES is a common problem that may often be overlooked clinically as it tends not to be a
common cause of permanent visual morbidity as traditionally measured.3 However, the present
study suggests that DES can have a significant impact on visual function that can diminish a
person’s quality of everyday living. More specifically, the present study shows that crucial
daily activities of modern living such as reading, computer use, professional work, driving,
and TV watching are all negatively impacted by DES.
In general, visual function and quality of life are important outcomes in the evaluation of
therapeutic decisions as well as in the assessment of the economic and public health impact of
any ocular condition. In addition to our report, there is accumulating evidence of an impact of
DES on quality of life measures.17, 25, 26 One such study utilized utility assessment, which
yields a single measure of impact of DES. Utility scores that are anchored at perfect health
(utility=1) and death (utility=0) can be compared across various health outcomes. In this way,
the impact of different health states on patient’s perspective of their quality of life as well as
quality-adjusted life years can be compared. Schiffman et al. showed that DES reduced quality
of life with mean comorbidity-adjusted utility scores ranging from 0.62 for severe DES to 0.78
for mild DES; which compared to utility scores of 0.75 and 0.72 for moderate and moderate
to severe angina pectoris (class III/IV).17
Nichols et al. used the National Eye Institute Visual Function Questionnaire 25 (NEI VFQ-25),
a generic vision-related quality of life tool designed to measure the impact of ocular disorders
such as glaucoma, cataract and age-related macular degeneration to study vision-related quality
of life among predominantly mild to moderate DES patients, particularly in relation to reported
ocular pain.26 In these patients, the pain and discomfort subscale of this instrument had the
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lowest score of all the subscales (83.8%). Others have observed statistically significant
differences in both the generic SF-36 quality of life scale as well as a DES-specific quality of
life instrument, the Impact of Dry Eye on Everyday Life (IDEEL) questionnaire, across varying
levels of DES severity.18
Others have devised measures of functional visual acuity (FVA) that may better simulate vision
requirements for daily acts of gazing with unconscious blink suppression, such as that which
occurs during activities of modern living including computer use, reading, and driving.12,
27, 28 People with DES blink twice as often as normal controls under relaxed conditions10
and this compensatory action probably stimulates tear secretion and spreading on the ocular
surface and might result in a normal VA using standard testing. However, DES is associated
with an unstable tear film as compared to the normal state29 and consequently a measure such
as FVA might still be reduced.12, 27, 28 In one such study, the reported average FVA of DES
patients was 20/71,28 which is just less than the acuity generally required for licensure for
nighttime driving in most US states.30 There is currently little if any information available on
the potential impact of conditions such as DES which may not affect VA as measured in the
clinic, but which may nevertheless impact vision while driving.12, 27, 28, 30–32 It is estimated
that the proportion of the population >65 years of age will double from its current levels to
20% of the total population (or 71.5 million people) by the year 2030.33 Studies have
demonstrated a reduction in the rate of blinking with increased driving speed, which can result
in further tear film instability in subjects with DES.31, 34 Our data in conjunction with those
from studies of FVA12, 27, 28 and tear instability in subjects with DES29 suggest that
consideration may need to be given to the impact of conditions like DES that may result in
fluctuating vision, reduced contrast sensitivity, or increased glare disability.32, 35, 36
The present study was limited by our classification of DES based on participant responses to
our short dry eye questionnaire. However, our prior work on validation of this questionnaire-
based assessment of DES showed a good balance of sensitivity and specificity versus
commonly used clinical diagnostic tests for DES.37 Moreover, misclassification of DES status
would tend to bias results toward the null and therefore is unlikely to explain the positive
findings of the present study. Nonetheless, we do not know the severity of DES in our
population and could not differentiate possible differences in visual function between mild and
more severe cases. Additionally, our subjects are more educated and somewhat healthier than
the general population and therefore results should be generalized only cautiously. However,
by studying this group of health care professionals, we achieved a high participation rate and
the higher level of health-related education and awareness of our study population may have
aided participants’ ability to respond accurately to these questions. The questionnaire-based
assessment of vision-related quality of life is also subject to possible bias or confounding if
patients with versus without dry eye would, for some reason other than dry eye, tend to answer
these questions differently. In this regard, however, our finding of a significant impact on
activities for which sustained visual attention is important is consistent with those of other
groups who have used alternative methodologies such as functional visual acuity measurement.
The interface between the tear film and the surrounding air represents the largest refractive
index differential in the human optical system and is consequently of critical importance for
clear vision. DES patients with an unstable tear film can usually clear a blurred image
temporarily by blinking frequently to redistribute the tear film over the ocular surface.
However, this may not be sustainable during activities requiring prolonged gazing, and those
with more severe symptoms may experience difficulty keeping their eyes open. Our findings
of nearly 3 and 5-fold increased risks of having problems with activities such as reading,
computer use and professional work among both women and men with DES who did and did
not use artificial tears, respectively, support and extend those of prior studies by pointing to
specific areas of functioning that are problematic among people with DES. In future studies,
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it would be interesting to examine whether environmental conditions such as a patients
proximity to air conditioning or heating vents, ambient humidity, and similar factors might
modify the association between dry eye and visual functioning.
In summary, findings of the present study indicate that DES is associated with an adverse
impact on vision-related quality of life. Several common tasks of daily living such as reading
and driving are adversely affected by this condition. These data add further weight to the
consideration of DES as a significant public health problem that deserves further study.
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Figure 1.
Presented are the separate and pooled results for the association between DES and reported
problems with selected activities of daily living, adjusted for potential confounding factors.
The center of each square indicates the odds ratio (OR), and the size of the square is proportional
to the percent weight each study contributed to the pooled estimate. The horizontal line
bisecting each square represents the 95% confidence interval for the OR. The random-effects
pooled OR and 95% CI are indicated by the unshaded diamonds. Estimates greater than one
signify that subjects with DES were more likely to report having problems with that particular
activity.
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Figure 2.
Presented are the separate and pooled findings for the association between DES and overall
reported problems with activities of daily living, separately among those who did versus did
not report any artificial tear use. The center of each square indicates the odds ratio (OR), and
the size of the square is proportional to the percent weight each study contributed to the pooled
estimate. The horizontal line bisecting each square represents the 95% confidence interval for
the OR. The random-effects pooled OR and 95% CI is indicated by the unshaded diamond.
Estimates greater than one signify that subjects with DES were more likely to report problems
with vision-related activities of daily living.
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Table
Baseline characteristics of study participants, according to presence of severe symptoms or a clinical diagnosis
of dry eye syndrome (DES)
Females (n=385)* Males (n=204)†
Baseline Characteristics DES (n=135) No DES (n=250) DES (n=55) No DES (n=149)
Age in years, mean (SD) 57.4 (6.9) 57.8 (7.2) 71.1 (8.1) 70.7 (8.4)
Race, %
 White 97.7 97.2 96.4 99.3
 Other 2.3 2.8 3.6 0.7
Highest Educational Level, %
 LPN/LVN‡ 11.9 11.4
 2 year associate RN§ 10.4 9.8
 3 year RN degree 26.9 30.6
 Bachelors degree 20.9 24.9
 Masters degree 24.6 17.1
 Doctoral degree 5.2 6.1 100. 100.
Household Income, %¶
 <$10,000 0.8 0.9
 $10,000–19,999 3.1 2.2
 $20,000–29,999 10.9 7.0
 $30,000–39,999 12.5 12.2
 $40,000–49,999 11.7 17.0
 $50,000–99,999 47.7 46.7
 ≥$100,000 13.3 14.0
Eye exam in the past 2 years, %¶ 88.0 84.8
Postmenopausal Hormone Therapy, %#
 Current 45.9 48.0
 Past 9.6 4.0
 Never 44.4 48.0
Hypertension, % 28.1 30.0 64.1 52.8
Diabetes mellitus, % 2.2 3.6 5.4 9.4
Benign prostate hypertrophy, %# 40.0 30.9
Sjogren’s syndrome, % 4.4 1.2 0.5 0.0
Other connective tissue disease, %¶ 4.4 2.0
Use of artificial tears, %
 Once per day 16.3 4.0 5.5 2.0
 Twice per day 15.6 4.0 12.7 0.7
 ≥Three times per day 11.1 1.2 20.0 1.3
*
Female participants are a selected subgroup of the Women’s Health Study
†
Male participants are a selected subgroup of the Physicians’ Health Study
‡
LPN=Licensed practical nurse; LVN=Licensed visiting nurse
§
RN=Registered nurse
¶
Data on income, having an eye exam in the past 2 years, and history of connective tissue disease were not available for the male participants.
#
Applies to only one sex
Am J Ophthalmol. Author manuscript; available in PMC 2008 March 1.
